Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2025-12-25 @ 5:27 PM
Study NCT ID:
NCT04889404
Status:
COMPLETED
Last Update Posted:
2025-04-15
First Post:
2021-05-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-22
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-06
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-12
First Submit QC Date:
None
Study First Post Date:
2021-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-14
Last Update Post Date:
2025-04-15
Last Update Post Date Type:
ACTUAL